Interventions for cisplatin-induced hearing loss in children and adolescents with cancer.

Authors

David R Freyer
Penelope Brock
Kristin Knight
Gregory Reaman, George Washington University
Sandra Cabral
Paula D Robinson
Lillian Sung

Document Type

Journal Article

Publication Date

8-1-2019

Journal

Lancet Child & Adolescent Health

Volume

3

Issue

8

Inclusive Pages

578-584

DOI

10.1016/S2352-4642(19)30115-4

Keywords

Acetylcysteine; Adolescent; Amifostine; Anti-Inflammatory Agents; Antineoplastic Agents; Chelating Agents; Child; Cisplatin; Cytoprotection; Dexamethasone; Disulfiram; Ditiocarb; Humans; Neoplasms; Ototoxicity; Thiosulfates

Comments

Epub 2019 May 31

APA Citation

Freyer, D., Brock, P., Knight, K., Reaman, G., Cabral, S., Robinson, P., & Sung, L. (2019). Interventions for cisplatin-induced hearing loss in children and adolescents with cancer.. Lancet Child & Adolescent Health, 3 (8). http://dx.doi.org/10.1016/S2352-4642(19)30115-4

Peer Reviewed

1